
James Kang
Senior Foreign AttorneyIntroduction
James is a Senior Foreign Attorney at Shin & Kim whose practice spans a broad range of cross-border corporate transactions, including M&A, joint ventures, carve-outs, investments and international capital markets transactions. He has extensive experience representing Korean and global private equity firms, Korean conglomerates and listed Korean companies on their cross-border deals.
James also has particular expertise in M&A insurance. He advises both transaction parties and insurers on W&I insurance and the other insurance products used in M&A transactions.
Areas of Expertise
Professional Career
- 2022-PresentShin & Kim LLC
- 2019-2022Yulchon LLC
- 2017-2019McCabes Lawyers, Sydney, Australia
- 2014-2017Slater and Gordon Lawyers, Sydney, Australia
Key Experience
- Advised on MBK Partners and Youngpoong's tender offer for Korea Zinc and the ensuing contest for control
- Advised on SK Discovery and Hahn & Company's sale of renewable energy developer SK eternix to KKR
- Advised Centurium Capital (the firm behind Luckin Coffee) on its acquisition of Blue Bottle Coffee from Nestlé
- Advised HD Korea Shipbuilding & Offshore Engineering on the merger of HD Hyundai Heavy Industries and HD Hyundai Mipo
- Advised on Boryung's acquisition of global rights to Sanofi's oncology drug Taxotere
- Advised KRAFTON on its investment in K-pop label THEBLACKLABEL
- Advised on Kyobo Life's acquisition of SBI Savings Bank, Korea's largest savings bank
- Advised on Clarios' acquisition of UCAP Power, parent of Maxwell Technologies Korea
- Advised on LG Innotek's strategic investment in U.S. LiDAR company Aeva
- Advised on Asia Pulp & Paper's acquisition of MSS Holdings (Monalisa, Ssangyong C&B) from Morgan Stanley PE
- Advised on EcoPro Innovation's investment in ASX-listed lithium developer Green Technology Metals
- Advised on Meritz Securities' investment in Lotus Technology in connection with its NASDAQ listing
- Advised on OTPP's co-investment with MBK Partners in Medit
- Advised on Kyobo Life's joint venture with AXA Investment Managers
- Advised on KakaoPay's acquisition of a stake in NASDAQ-listed U.S. broker Siebert Financial
- Advised on Handsome's pre-IPO investment in luxury fashion group Lanvin Group
- Advised on Establishment of a cosmetics joint venture among Anchor Equity Partners, L'Oréal and Shilla Hotels
- Advised on Sale of KOSDAQ-listed aesthetic device maker Classys to Bain Capital
- Advised on Carlyle's acquisition of a 10% stake in Hyundai Glovis through a block trade
- Advised on KNW's acquisition of KOSDAQ-listed Solvay Korea (now Fluorine Korea)
- Advised on TPG's acquisition of Health Balance
- Advised on CJ CGV's sale of a stake in its Hong Kong subsidiary CGI Holdings to MBK Partners
- Advised on Big Hit Entertainment (now HYBE)'s acquisition of Pledis Entertainment, home of SEVENTEEN
- Advised on STIC Investments' Series H investment in Southeast Asian super app Grab
Education
- 2013University of Sydney (LL.B.)
- 2008University of Sydney (B.Com., Accounting)
Qualifications
- 2014Supreme Court of New South Wales and High Court of Australia
Languages
Korean, English
Professional Activities
Professional Accolades
- "Asia 40 Under 40", ALB, 2026
- "Rising Star” for M&A, Herald Economy, 2026
Media
-
2026.10.29
-
2025.12.05